BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8199046)

  • 21. Interferon-α suppressed granulocyte colony stimulating factor production is reversed by CL097, a TLR7/8 agonist.
    Tajuddin T; Ryan EJ; Norris S; Hegarty JE; O'Farrelly C
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1883-90. PubMed ID: 21092001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia.
    Liberati AM; Horisberger MA; Garofani P; De Angelis V; Ferrajoli A; Di Clemente F; Caricchi P; Adiuto D; Fedeli L; Palumbo B
    J Interferon Res; 1994 Dec; 14(6):349-55. PubMed ID: 7897254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon.
    Daito K; Suou T; Kawasaki H
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):303-16. PubMed ID: 8008980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts.
    Durante-Mangoni E; Iardino P; Utili R; Adinolfi LE; Ruggiero G
    Antivir Ther; 2006; 11(5):637-40. PubMed ID: 16964833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells.
    Paquette RL; Hsu NC; Kiertscher SM; Park AN; Tran L; Roth MD; Glaspy JA
    J Leukoc Biol; 1998 Sep; 64(3):358-67. PubMed ID: 9738663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of cancer patients with recombinant interferon-gamma induces release of endogenous tumor necrosis factor-alpha.
    Aulitzky WE; Aulitzky WK; Frick J; Herold M; Gastl G; Tilg H; Berger M; Huber C
    Immunobiology; 1990 Jun; 180(4-5):385-94. PubMed ID: 2118879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patients.
    Crispino S; Lissoni P; Ardizzoia A; Rovelli F; Perego MS; Grassi MG; Barni S; Pittalis S; Tancini G
    J Biol Regul Homeost Agents; 1993; 7(3):92-4. PubMed ID: 8135145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant alpha 2b interferon (alpha-2b-IFN), chlorambucil, and prednisone in advanced chronic lymphocytic leukemia (CLL).
    Mandelli F; Gastaldi R; Monarca B; Coluzzi S; De Rossi G
    Eur J Haematol; 1991 Jan; 46(1):58-9. PubMed ID: 1988312
    [No Abstract]   [Full Text] [Related]  

  • 29. Modulation of purine analogs- and chlorambucil-induced cytotoxicity by alpha-interferon and interleukin-2 in chronic lymphocytic leukemia.
    Morabito F; Callea I; Rodinò A; Messina G; Callea V; Iacopino P; Nobile F; Brugiatelli M
    Leukemia; 1995 Sep; 9(9):1450-5. PubMed ID: 7658711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GM-CSF raises serum levels of beta 2-microglobulin and thymidine kinase in patients with chronic lymphocytic leukaemia.
    Itälä M; Pelliniemi TT; Remes K
    Br J Haematol; 1996 Jul; 94(1):129-32. PubMed ID: 8757522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. alpha Interferon in chronic lymphocytic leukaemia.
    Montserrat E; Villamor N; Urbano-Ispizua A; Ribera JM; Rozman C
    Eur J Cancer; 1991; 27 Suppl 4():S74-7. PubMed ID: 1839211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant alpha-2b-interferon may restore natural-killer activity in patients with B-chronic lymphocytic leukemia.
    Villamor N; Reverter JC; Montserrat E; Urbano-Ispízua A; Vives-Corrons JL; Rozman C
    Leukemia; 1992 Jun; 6(6):547-52. PubMed ID: 1376376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of prednisolone and interferons on serum macrophage colony stimulating factor concentrations in chronic hepatitis B.
    Itoh Y; Okanoue T; Sakamoto S; Nishioji K; Kashima K
    J Hepatol; 1997 Feb; 26(2):244-52. PubMed ID: 9059942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.
    Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A
    J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gamma.
    Neuber K; Berg-Drewniock B; Volkenandt M; Neumaier M; Zeller W; Gross G; Ring J
    Dermatology; 1996; 192(2):110-5. PubMed ID: 8829490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha 2-interferon in B-cell chronic lymphocytic leukemia: clinical response, serum cytokine levels, and immunophenotype modulation.
    Morabito F; Callea V; Oliva B; Stelitano C; Vincelli I; Molica S; Alberti A; Brugiatelli M; Nobile F
    Leukemia; 1993 Mar; 7(3):366-71. PubMed ID: 7680399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
    Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
    J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage colony-stimulating factor is required for human monocyte survival and acts as a cofactor for their terminal differentiation to macrophages in vitro.
    Brugger W; Kreutz M; Andreesen R
    J Leukoc Biol; 1991 May; 49(5):483-8. PubMed ID: 2016569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between serum macrophage colony-stimulating factor levels and monocyte and thrombocyte counts in healthy, hypoxic, and septic term neonates.
    Oren H; Duman N; Abacioglu H; Ozkan H; Irken G
    Pediatrics; 2001 Aug; 108(2):329-32. PubMed ID: 11483796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.